Form D · Biotechnology
ACCELERON PHARMA INC
Cambridge, MA · CIK 0001280600
Offering snapshot reported Sep 27, 2013 · SEC filing
- Reported sold
- $10M Offering amount: $10M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 24, 2013 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 27, 2013 | Initial | $10,000,005 | No comparison | 1 | SEC filing |
| Jan 4, 2012 | Initial | $30,472,934 | No comparison | 47 | SEC filing |
| Jul 21, 2010 | Amendment | $10,250,006 | $1,894,585vs Jun 18, 2010 | 48 | SEC filing |
| Jun 18, 2010 | Initial | $8,355,421 | No comparison | 38 | SEC filing |
| Dec 15, 2009 | Initial | $10,951,121 | No comparison | 40 | SEC filing |
| Apr 7, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Nov 7, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Aug 10, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jan 6, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-203637
Source: Form D, filed Sep 27, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Peter Courossi | Executive |
| Steven Ertel | Executive |
| Anthony B Evnin | Director |
| Pat Gage | Director |
| Jean George | Director |
| George Golumbeski | Director |
| Carl L. Gordon | Director |
| Ed Kania | Director |
| Edwin M. Kania | Director |
| Edwin M. Kania, Jr. | Director |
| John Knopf | Director, Executive |
| Tom Maniatis | Director |
| Terry Mcguire | Director |
| Terrance G. Mcguire | Director |
| Kevin F. Mclaughlin | Executive |
| Richard F. Pops | Director |
| Jasbir Seehra | Executive |
| Matthew L. Sherman | Executive |
| Robert Steininger | Executive |
| Wylie W. Vale | Director |
| Joseph S. Zakrzewski | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
128 Sydney Street
Cambridge, MA, 02139
Cambridge, MA, 02139